Skip to content

Effect of Foot Bath on Pain, Sleep, and Comfort Levels After Abdominal Surgery

Effect of Foot Bath on Pain, Sleep, and Comfort Levels After Abdominal Surgery: A Randomized Controlled Trial

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07366567
Enrollment
96
Registered
2026-01-26
Start date
2025-12-29
Completion date
2026-12-30
Last updated
2026-01-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Postoperative, Sleep

Keywords

pain, foot bath, sleep quality, comfort

Brief summary

The aim of this study was to investigate the effects of foot bath application on pain level, comfort and sleep quality in the postoperative period. H1: Foot baths have a postoperative pain-reducing effect. H2: Foot baths have a postoperative comfort-enhancing effect. H3: Foot baths have a postoperative sleep-improving effect.

Detailed description

The research will be conducted with the participation of surgical patients who underwent abdominal surgery between December 2025 and December 2026 in the General Surgery Department of Tekirdag University Hospital. Using the G\*Power 3.1.9.4 program, the minimum number of people to be included in the sample was found to be 88 (44:44), assuming an effect size of 0.8 at a 95% confidence level and a 95% power ratio. To avoid the risk of sample loss, it was decided to include 48 patients in each group.

Interventions

OTHERFoot bath device

On the day of surgery, patients will receive a foot bath between 9:00 PM and 10:00 PM. Any socks or clothing on both feet will be removed. The feet will be visually and manually examined to determine if they show any signs of illness (pressure ulcers, discoloration, wounds, etc.). The patient will be informed that the foot bath device is disinfected before each use and that water-tight bags will be placed around the device to prevent contact between the foot and the water to facilitate repeated use. The water temperature will be adjusted to 41-42°C using an infrared thermometer (non-contact digital thermometer). Both feet will be placed inside the foot bath device. The patient's feet will remain in the foot bath device for 20 minutes. After the foot bath, the patient's feet will be thoroughly dried with a towel, and the patient will be re-dressed in their existing socks or anti-embolic stockings. Any side effects/adverse reactions, etc., related to the foot bath will be questioned and

Sponsors

Trakya University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Masking description

None (Open Label)

Intervention model description

Patients in the experimental group will receive a foot bath. Patients in the control group will not be intervened within the scope of the study.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* who are hospitalized in the General Surgery Clinic, * are on day 0 of surgery, * volunteer to participate in the study, * have no neuropsychiatric diagnosis and are not taking antipsychotic medications, * are over 18 years of age, * accept random selection, * and undergo abdominal surgery. * For the experimental group, all patients with no infectious diseases (shingles, fungal infections, eczema, warts, calluses), local infections (abscesses, etc.), open lesions/wounds, scar tissue, edema, hematomas, thrombophlebitis, deep vein thrombosis, lymphangitis, coagulation disorders, varicose veins, osteoporosis, osteomyelitis, hepatitis, degenerative joint diseases, neuropathy due to diabetes, toe deformities, recent fractures, dislocations, or ruptures of muscle fibers, tendons, or ligaments will be included in the sample.

Exclusion criteria

* patients who underwent multiple simultaneous surgeries along with abdominal surgery, * those with postoperative complications such as delirium, * those who underwent reoperation, * those with a pain score \>7 because it could affect sleep levels, * and those who received narcotic analgesics on postoperative day 0 due to pain will be excluded from the sample.

Design outcomes

Primary

MeasureTime frameDescription
Pain levelpostoperative period (first day)"Numerical rating scale" A score of 0 (zero) indicates no pain, while a score of 10 (ten) indicates unbearable pain.
sleep qualitypostoperative period (1st day)"The Richards-Campbell Sleep Questionnaire" Each item is scored on a visual analog scale from 0 to 100. Scores between 0 and 25 indicate very poor sleep, while scores between 76 and 100 indicate very good sleep.

Secondary

MeasureTime frameDescription
Adverse effectduring application and 12 hours of application.Adverse effect (Yes or No)

Countries

Turkey (Türkiye)

Contacts

CONTACTZEYNEP KIZILCIK ÖZKAN, Assco.Prof
zeynepozkan@trakya.edu.tr05056010101
CONTACTAyşe Nur Aktaş, Reg. Nurse
aysenuraktas24@gmail.com
STUDY_CHAIRZEYNEP KIZILCIK ÖZKAN, Assoc.Prof

Trakya University

PRINCIPAL_INVESTIGATORAyşe Nur Aktaş, Reg.Nurse

Trakya University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026